// App-Quantinova.ai

e24089 : Therapeutic response monitoring using digital PCR for patient-specific circulating tumor DNA identified by an esophageal squamous cell carcinoma-specific sequencing panel.

Researchers

Presenter

  • Takeshi Iwaya

Principal Investigators

  • Fumitaka Endo

  • Yasushi Sasaki

  • Yuji Akiyama

  • Akira Sasaki

  • Mari Masuda

  • Tesshi Yamada

  • Takashi Tokino

  • Satoshi Nishizuka

Medical Centers

  • Molecular Therapeutics Laboratory, Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  • Department of Neurosurgery, Iwate Medical University, Morioka, Japan

  • Sapporo Medical University, Sapporo, Japan

  • Department of Surgery, Jichi Medical University School of Medicine, Shimotsuke, Japan

  • National Cancer Center Research Institute, Tokyo, Japan

  • National Cancer Center Research Institute, Tokyo, Japan

  • Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan

  • Iwate Medical University School of Medicine, Morioka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • Docetaxel

  • Adrucil injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved